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SUMMARY 
Objectives: To examine sputum specimens from 
patients with persistent bronchopulmonary disor-
ders for mycobacterium species and to characterize 
the recovered isolates with a view to determining 
the extent of involvement of environmental myco-
bacteria in pulmonary infections. 
Design: Analytical study using standard micros-
copy, culture and biochemical test for the identifi-
cation of mycobacterium species. 
Setting: Jos University Teaching Hospital (JUTH) 
and 2 referral hospitals: Plateau Specialist Hospital 
and Evangelical Churches of West Africa (ECWA) 
Evangel Hospital in Jos, Nigeria. 
Participants: Three hundred and twenty nine 
(329) volunteer new patients seen at the chest 
clinic and general out patient departments with 
broncho-pulmonary disorders. Patients already on 
anti-tuberculosis were excluded from the study. 
Interventions: Subjects were administered anti-
tuberculosis drugs and or other treatment regimes 
after proper diagnosis  
Results: Sixty-five (65) mycobacterial isolates 
were obtained and differentiated into human tuber-
cle bacilli, bovine and or environmental (atypical) 
mycobacteria on the basis of nine identification 
tests. Of the 65 mycobacterial isolates subjected to 
the tests, 40 (61.54%) were identified as mycobac-
terium tuberculosis, 10 (15.38%) as M. bovis and 
15 (23.08%) as environmental mycobacteria. 
Among the environmental group, 9 (20.69%) were 
classified as M. avium 3 (3.45%) each as M. kan-
sasi and M.  fortuitum. 
Conclusions: The study confirms the involvement 
of bovine and environmental mycobacteria in pul-
monary infections. This may be related to the ris-
ing prevalence of HIV/AIDS globally. The need 
for adequate bacteriological analysis in current-day 
diagnosis of pulmonary tuberculosis in indicated. 
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INTRODUCTION 
Environmental (Atypical or “anonymous”) myco-
bacteria have been documented to be involved in 
human pulmonary infections in both developed 
and developing countries1,2,3,4,5. Incidence rates of 
between 2-20% for atypical mycobacteriosis have 
been reported from various parts of the world5,6,7. 
In a World Health Organisation assisted survey of 
various parts of Nigeria in 1963, a 6% National 
Incidence rate of atypical mycobacteria was re-
ported1. Also, in Lagos, Nigeria, Idigbe et al5 re-
ported an incidence rate of 11% for atypical my-
cobacteriosis. The only two reports of the in-
volvement of bovine mycobacteria in human pul-
monary infections in Nigeria are those of Alhaji 
and Schnurrenberger8 who documented a 10% 
incidence rate in four of the then Northern States 
of the country and Idigbe et al5 documented a 
3.9% incidence rate in Lagos. 
 
In the last few decades, the incidence of classical 
tuberculosis has been on the increase alongside 
tuberculosis-like disease caused by environmental 
mycobacteria. The apparent increase in the fre-
quency of isolation of these mycobacteria from 
clinical specimens and the mounting evidence of 
their aetiology in severe pulmonary diseases in 
severe pulmonary diseases in man is currently 
generating concern as far as the accurate diagnosis 
and treatment of classical tuberculosis is con-
cerned. Clinically and radiologically, the pulmo-
nary diseases produced by environmental strains 
are indistinguishable from classical pulmonary 
tuberculosis, whereas the two diseases present 
fundamental differences in their epidemiology, 
management and prognosis5. It is therefore impor-
tant that clinicians and bacteriologists appreciate 
the fact that not all Acid Fast Bacillus (AFB) 
found in sputum are Mycobacterium tuberculosis. 
 
This paper reports the results of the differentiation 
of 65 mycobacteria isolates obtained from patients 
in Jos, Nigeria. 
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MATERIALS AND METHODS 
Study Population 
Sputum samples were collected from three hun-
dred and twenty-nine (329) new patients seen at 
the Chest Clinic and general out-patient depart-
ment of Jos University Teaching Hospital (JUTH), 
Plateau Specialist Hospital and Evangelical 
Churches of West Africa (ECWA) Evangel Hospi-
tal all in Nigeria with broncho-pulmonary features 
including fever, loss of weight, persistent produc-
tive cough lasting for ≥ 4 weeks, haemoptysis and 
abnormal chest X-ray among others. The patients 
were screened for AFB in their sputum. The first 
sputum samples were collected on the first day of 
reporting to the hospital; thereafter first early 
morning sputum specimens were collected for 2 
consecutive days. 
 
Bacteriological Analysis of Sputum Samples 
The sputum samples were examined by microcopy 
and culture. The samples were first digested and 
concentrated by Petroff’s method9. Smears of the 
final deposits from the various specimens were 
stained by the Ziehl-Neelsen (Z-N) method and 
examined under oil immersion using a binocular 
light microscope. 
 
Loopfuls of the various deposits were also evenly 
spread on to the surfaces of a pair of Lowenstein-
Jensen (L-J) slopes, incubated at 37oC and ob-
served daily on the first week and subsequently 
twice a week for 8 weeks. Slopes without visible 
growth after 8 weeks were discarded and recorded 
as negative, while slopes showing mycobacterial 
growth were recorded as positive. All such 
growths were checked for acid fast properties by 
Z-N microscopy. A case was taken to be positive 
when visible growth of pure colonies of AFB was 
obtained from at least one of the 3 sputum samples 
per case.  
 
Classification of Isolates 
Subcultures of each of the primary isolates were 
carried out on fresh L-J slopes and the resultant 
growths were again checked for purity and acid 
fast properties by microscopy.  
 
Differentiation of isolates into human, bovine and 
other mycobacteria was based mainly on the abili-
ties of the isolates to produce niacin or reduce ni-
trates to nitrites during growth. Classification of 
environmental isolates using Runyon’s10 diagnos-
tics scheme was done by testing all stains for ra-
pidity of growth, pigment production and photo-
chromogenesis. Strains growing in less than 7 days 
were classified as rapid growers while strains 
growing after 7 days were classified as slow grow-
ers. Photochromogens were classified as Runyon 
group 1, scotochromogens as group 3 and rapid 
growers as group 4. 
 
Identification of the Runyon group 3 strains was 
based on the catalase activity of their broth cul-
tures after heating at 68oC for 20 minutes. The 
ability to hydrolyse Tween 80 and reduce nitrate to 
nitrite was examined in group 1 isolates. For group 
3, isolates were screened mainly for their capabil-
ity to reduce tellurite to tellurium within 3-4 days, 
while positivity for growth on MacConkey agar 
and the Arylsuphatase tests were used as differen-
tial tests in group 4 isolates.  
 
A mycobacterium strain earlier identified as M. 
tuberculosis and a strain of M. fortuitum (NCTC 
8573) were included in all the tests as positive and 
negative controls respectively. 
 
Statistical analysis 
The data obtained were subjected to the Chi-
squared test using a probability of P=0.05 as the 
level of significance. 
 
RESULTS 
A total of 65 isolates of mycobacteria were ob-
tained. The isolates and control organisms were 
subjected to all the various culture and biochemi-
cal tests and the results (Table 1). In terms of 
Runyon’s groupings, none of the isolates gave 
positive reactions in the scotochromogenesis test 
and since tests were repeated several times with 
consistent results, it was taken that none belonged 
to Runyon’s group 2.  
 
Three of the isolates were positive in the photo-
chromogenesis test, developing various shades of 
yellow to orange pigments after exposure to light. 
Three strains were classified as Runyon group 1 
mycobacteria. The 62 non-chromogenic isolates 
were differentiated into rapid and slow growers on 
the basis of their growth rate on L-J slopes. Three 
isolates consistently showed visible, well matured 
colonies within 4-5 days of incubation. These iso-
lates were taken as rapid growers and classified as 
Runyon group 4 strains. With the other isolates, 
growths on LJ slopes were observed after 10-14 
days incubation and were therefore classified as 
slow growers. 
 
Essentially all mycobacteria were catalase posi-
tive. Results from repeated tests were consistent 
and showed that while nine of the isolates still had 
catalase activities after the heat treatment, 50 were 
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catalase negative. The nine catalase positive iso-
lates were then classified as group 3 mycobacteria 
while the 50 negative isolates were assumed to be 
either M. tuberculosis or M. bovis. Ten of the 50 
negative isolates were consistently negative in 
producing niacin and reducing nitrate to nitrite and 
were classified as M. bovis. The 40 isolates that 
produced niacin and reduced nitrate were classi-
fied as M. tuberculosis.  
 
Table 1 Characterization of mycobacteria iso-
lates/strain 
 
Tests Isolates Controls 
A. Culture  
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Overall, of the 65 isolates 40 (61.54%) were iden-
tified as M .tuberculosis, 10 (15.38%) as M. bovis, 
9 (13.85%) as M. avium and 3 (4.61%) each for M. 
kansasi and M. fortuition. 
 
Table 2 shows the age and sex distribution of the 
identified cases with environmental and bovine 
mycobacteria.  
 
Table 2 Age and sex distribution of cases with 
environmental and bovine mycobacteria 
 
 Environmental Bovine 









































Total 10 5 9 1 
DISCUSSION 
The involvement of environmental mycobacteria 
strains in human pulmonary infection in the devel-
oped and developing countries has been frequently 
reported. In these papers, incidence rates of 2-10% 
for atypical mycobacteria were noted4,5,11,12. Data 
in the present study confirms the involvement of 
environmental mycobacteria in human pulmonary 
infection in Jos. An incidence rate of 23.08% for 
human atypical mycobacteriosis reported for vari-
ous parts of the world6,7 but lower than the preva-
lence rate of 26.6% for atypical tuberculoid bacilli 
earlier reported by Allanana et al12 in Jos. Strains 
of M. kansasii, M. avium and M. fortuitum were 
isolated from various patients within the period. 
Idigbe et al13 in a report from Lagos not only con-
firmed the involvement of atypical mycobacteria 
in human infections but indicated a progressive 
increase in the prevalence of atypical mycobacteria 
from 14.6% in 1982 to 30.1% in 1992. Again, 
strains of M. kansasii, M. avium, M.fortuitum and 
M. xenopi were isolated from various patients. The 
resurgence of tuberculosis worldwide has been 
attributed to the rising prevalence of HIV/AIDS. 
At the end of 2001, an estimated 40 million people 
globally were living with HIV according to the 
Joint United National Programme on HIV/AIDS14. 
In Nigeria, a prevalence rate 5% was documented 
within the period15.  
 
However, despite this involvement of atypical my-
cobacteria, results from this study have incrimi-
nated M .tuberculosis as the most prevalent causa-
tive agent of the cumulative number of positive TB 
cases detected in Jos. This situation is not different 
from earlier reports by Allanana et al12 in Jos, 
Idigbe et al13 in Lagos and some other parts of the 
world16. 
 
Isolation of species of atypical mycobacteria from 
patients in this study suggests the pathogenic role 
of such atypical mycobacteria in these patients. 
The most important feature of atypical mycobacte-
ria is the ability of some of them to produce tuber-
culosis-like disease frequently resistant to usual 
tuberculosis therapy17,18. In most of Nigeria and 
other developing countries, diagnosis of tuberculo-
sis is usually based on such symptoms as fever, 
loss of weight, persistent productive cough, haem-
optysis and an abnormal chest X-ray. Where labo-
ratory facilities are available the presence of acid 
fast bacilli in clinical specimens is also used in 
diagnosis. However, observations from this study 
and several other studies seem to further highlight 
the increasing awareness that the presence of acid 
fast bacilli in sputum, X-ray abnormality or mere 
 
 
December 2006 J.D. Mawak et al Human pulmonary infection 
 135
isolation of mycobacterium colonies on L-J slopes 
is not enough to establish a case of classical pul-
monary tuberculosis. Identification of the myco-
bacterium isolate is inevitably necessary. 
 
A significant observation in this study was that all 
the 15 cases of atypical mycobacteriosis before 
bacteriological identification of the isolates were 
queried as pulmonary tuberculosis (PTB) and sent 
to the laboratory for AFB microscopy. A positive 
AFB microscopy result and other relevant clinical 
data would result in the patients being placed on 
anti-tuberculosis regimens. This result in most of 
the cases would have been little or no response to 
therapy after prolonged treatment. 
 
Evidence from the study also indicated the in-
volvement of bovine mycobacteria in human pul-
monary infections in Jos. An prevalence of 15.4% 
was documented. 
 
Other reports of the involvement of bovine myco-
bacteria in human pulmonary infections in Nigeria 
were those of Alhaji and Schurrenberger8 who 
documented a 10% incidence rate in four of the 
Northern States of the country and Idigbe et al5 
who reported a 3.9% incidence rate of bovine my-
cobacteriosis in Lagos. Results of the present study 
in the Northern part of Nigeria revealed a preva-
lence rate of 15.4% for bovine mycobacteriosis. 
Thus, it would appear that the prevalence of bo-
vine mycobacteriosis is higher in the Northern 
than the Southern part of the country. 
 
A more detailed epidemiological survey of various 
parts of the country would be needed to confirm 
this observation. However, it is likely that the hy-
pothesis could be correct because culturally a sig-
nificant proportion of the Northern population are 
nomadic pastoralist and thus have more frequent 
contact with domestic animals than the Southern 
population. Several workers have associated bo-
vine mycobacteriosis with cattle17,19. 
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